{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:33:37Z","timestamp":1776404017734,"version":"3.51.2"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015752","name":"British Columbia Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015752","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jcf.2022.12.013","type":"journal-article","created":{"date-parts":[[2022,12,25]],"date-time":"2022-12-25T00:43:45Z","timestamp":1671929025000},"page":"306-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pulmonary exacerbation inflammatory phenotypes in adults with cystic fibrosis"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4567-5007","authenticated-orcid":false,"given":"Kang","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8195-8429","authenticated-orcid":false,"given":"Sung Moon","family":"Huh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace Y","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiah","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4241-8718","authenticated-orcid":false,"given":"Alessandro N.","family":"Franciosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pearce G","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley S","family":"Quon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcf.2022.12.013_bib0001","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/153.4.345","article-title":"Predictive 5-year survivorship model of cystic fibrosis","volume":"153","author":"Liou","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.jcf.2022.12.013_bib0002","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/thx.2006.060889","article-title":"Exacerbations in cystic fibrosis. 1: epidemiology and pathogenesis","volume":"62","author":"Goss","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2022.12.013_bib0003","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S1569-1993(11)60012-X","article-title":"Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials","volume":"10","author":"Bilton","year":"2011","journal-title":"J Cystic Fibrosis"},{"key":"10.1016\/j.jcf.2022.12.013_bib0004","first-page":"1120","volume":"11","author":"Chmiel","year":"2014"},{"issue":"6","key":"10.1016\/j.jcf.2022.12.013_bib0005","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jcf.2018.08.014","article-title":"Defining antimicrobial resistance in cystic fibrosis","volume":"17","author":"Kidd","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2022.12.013_bib0006","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcf.2019.10.006","article-title":"Antimicrobial resistance in cystic fibrosis: a Delphi approach to defining best practices","volume":"19","author":"Zemanick","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2022.12.013_bib0007","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers","volume":"184","author":"Bafadhel","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.jcf.2022.12.013_bib0008","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/S2213-2600(15)00459-2","article-title":"Hyperinflation in COPD exacerbations","volume":"3","author":"van Geffen","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.jcf.2022.12.013_bib0009","doi-asserted-by":"crossref","first-page":"e57678","DOI":"10.1371\/journal.pone.0057678","article-title":"Sputum inflammatory cell-based classification of patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"8","author":"Gao","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.jcf.2022.12.013_bib0010","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jaci.2018.06.008","article-title":"Paucigranulocytic asthma: uncoupling of airway obstruction from inflammation","volume":"143","author":"Tliba","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jcf.2022.12.013_bib0011","series-title":"Ann Am Thorac Soc","article-title":"Acute pulmonary exacerbation phenotypes in patients with cystic fibrosis","author":"Carter","year":"2022"},{"key":"10.1016\/j.jcf.2022.12.013_bib0012","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.bbi.2020.01.023","article-title":"To exclude or not to exclude: considerations and recommendations for c-reactive protein values higher than 10 mg\/L","volume":"87","author":"Mac Giollabhui","year":"2020","journal-title":"Brain Behav Immun"},{"issue":"7","key":"10.1016\/j.jcf.2022.12.013_bib0013","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.bbi.2009.04.005","article-title":"To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers","volume":"23","author":"O'Connor","year":"2009","journal-title":"Brain Behav Immun"},{"issue":"5","key":"10.1016\/j.jcf.2022.12.013_bib0014","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcf.2017.04.005","article-title":"Standardized Treatment of Pulmonary Exacerbations (STOP) study: observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations","volume":"16","author":"Sanders","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.12.013_bib0015","unstructured":"Cystic Fibrosis Respiratory Symptom Diary (CFRSD) including the Chronic Respiratory Infection Symptom Scale (CRISS) user manual U.S. version 2.0. 2016."},{"issue":"3","key":"10.1016\/j.jcf.2022.12.013_bib0016","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/ppul.24577","article-title":"Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosis","volume":"55","author":"Wagener","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.jcf.2022.12.013_bib0017","article-title":"Exploratory factor analysis: a five-step guide for novices","volume":"8","author":"Williams","year":"2010","journal-title":"Australasian J Paramed"},{"key":"10.1016\/j.jcf.2022.12.013_bib0018","series-title":"Exploratory and confirmatory factor analysis: understanding concepts and applications","author":"Thompson","year":"2004"},{"key":"10.1016\/j.jcf.2022.12.013_bib0019","doi-asserted-by":"crossref","unstructured":"Brock G., Pihur V., Datta S., Datta S. clValid: an R Package for Cluster Validation. 2008. 2008;25(4):22.","DOI":"10.18637\/jss.v025.i04"},{"issue":"9","key":"10.1016\/j.jcf.2022.12.013_bib0020","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S2213-2600(15)00242-8","article-title":"Heterogeneity of chronic obstructive pulmonary disease exacerbations: a two-axes classification proposal","volume":"3","author":"Lopez-Campos","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2022.12.013_bib0021","first-page":"589","volume":"15","author":"Saavedra","year":"2018"},{"issue":"1","key":"10.1016\/j.jcf.2022.12.013_bib0022","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-80967-5","article-title":"Personalized treatment options for chronic diseases using precision cohort analytics","volume":"11","author":"Ng","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2022.12.013_bib0023","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4137\/MBI.S10792","article-title":"Evolution and impact of bacterial drug resistance in the context of cystic fibrosis disease and nosocomial settings","volume":"6","author":"Sriramulu","year":"2013","journal-title":"Microbiol Insights"},{"issue":"2","key":"10.1016\/j.jcf.2022.12.013_bib0024","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1378\/chest.09-3074","article-title":"Accurate Assessment of Adherence Self-Report and Clinician Report vs Electronic Monitoring of Nebulizers","volume":"140","author":"Daniels","year":"2011","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jcf.2022.12.013_bib0025","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcf.2011.03.005","article-title":"Longitudinal association between medication adherence and lung health in people with cystic fibrosis","volume":"10","author":"Eakin","year":"2011","journal-title":"J Cystic Fibrosis"},{"issue":"4","key":"10.1016\/j.jcf.2022.12.013_bib0026","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/thoraxjnl-2016-208450","article-title":"Effect of pulmonary exacerbations treated with oral antibiotics on clinical outcomes in cystic fibrosis","volume":"72","author":"Stanojevic","year":"2017","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.jcf.2022.12.013_bib0027","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1164\/rccm.201407-1365LE","article-title":"Measurement of serum calprotectin in stable patients predicts exacerbation and lung function decline in cystic fibrosis","volume":"191","author":"Reid","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jcf.2022.12.013_bib0028","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.chest.2019.05.017","article-title":"Proteomic profiling to identify blood biomarkers predictive of response to azithromycin in children and adolescents with cystic fibrosis","volume":"156","author":"Dong","year":"2019","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.jcf.2022.12.013_bib0029","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","article-title":"IL-10: the master regulator of immunity to infection","volume":"180","author":"Couper","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jcf.2022.12.013_bib0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.jcf.2022.12.013_bib0031","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01102-2016","article-title":"Doxycycline improves clinical outcomes during cystic fibrosis exacerbations","volume":"49","author":"Xu","year":"2017","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jcf.2022.12.013_bib0032","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jcf.2017.04.003","article-title":"Standardized Treatment of Pulmonary Exacerbations (STOP) study: physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations","volume":"16","author":"West","year":"2017","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322014333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322014333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:48:23Z","timestamp":1761601703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199322014333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1569199322014333"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2022.12.013","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary exacerbation inflammatory phenotypes in adults with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2022.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}